Add like
Add dislike
Add to saved papers

Thyroid cytology in Pakistan; an institutional audit of AUS/FLUS category.

BACKGROUND: Fine needle aspiration cytology (FNAC) along with the thyroid ultrasound is an important tool in evaluation of the thyroid nodules & help in further management of these patients i-e decision of surgical intervention vs follow-up. The Bethesda system for reporting thyroid cytopathology (TBSRTC) category III of Atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) has risk of malignancy ranging from 5-15%. The aim of the present study was to describe the frequency of AUS/FLUS in thyroid gland FNACs and the surgical outcomes of these cases.

METHODS: The integrated laboratory management system (ILMS) retrieved the thyroid FNACs from 2010-2018 and subsequent surgical pathology specimens. For the AUS/FLUS cases, data regarding patients' demographics, cytology and histological diagnoses were recorded. The results were tabulated as the overall frequency of AUS/FLUS in thyroid FNACs, cytohisto correlation (benign and malignant) and risk of malignancy (ROM).

RESULTS: During 9-years, 256 (10.9%) cases out of 2342 thyroid FNACs were reported as AUS/FLUS at our institution. Mean age was 43.5 year. Majority (70.3%) of patients were female. Seventy-two of 104 resection specimens (69.2%) were reported benign and 32 cases (30.7%) had malignant diagnosis. Upper-bound ROM was 30.7% (32 cases with malignant diagnosis out of 104 resection specimens). Lower-bound ROM was calculated as 12.5% (32 cases with malignant diagnosis out of 256 total AUS diagnosis).

CONCLUSION: The AUS/FLUS category of thyroid cytology & associated risk of malignancy remain an evolving area of thyroid cytology. Individual institution should monitor the frequency & include ROM in the dashboard indicators to remain within the recommended range.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app